International Flavors & Fragrances Inc (IFF)

International Flavors & Fragrances Inc. recently observed three insider transactions. While Officer Michael DeVeau initiated a proposed sale of 8,825 shares valued at approximately $754,969, total buying activity reached $20,317,854. This follows a positive earnings report where the company beat expectations by 5.13%, coinciding with a 7.9% stock price increase over the last quarter.
Ticker: IFF Exchange: NYS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for International Flavors & Fragrances Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 7 Aug 2026
Value US$1,852,605.42 | Price 465.20 | Shares 91,323 (+30.9%)
Proposed sale 7 Aug 2026
Value US$4,025,255.98 | Price 250.10 | Shares 48,795
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-10 2026-08-07 S Sale

Controller & CAO

Officer
91,323 +30.9%
465.20
US$1,852,605
91,323 +30.9% 465.20 US$1,852,605
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
48,795
250.10
US$4,025,256
48,795 250.10 US$4,025,256
2026-08-07 2026-08-06 S Sale

EVP, CFO

Officer
14,565 +24.9%
115.04
US$1,460,864
14,565 +24.9% 115.04 US$1,460,864
2026-08-06 2026-08-06 PrS Proposed sale

Officer

Officer
1,000
85.55
US$100,000
1,000 85.55 US$100,000
2026-06-02 2026-06-01 B Purchase Non-Executive Director
260,000 +10.7%
74.28
US$19,312,280
260,000 +10.7% 74.28 US$19,312,280
2026-06-02 2026-06-01 B Purchase Non-Executive Director
13,500 +45.5%
74.49
US$1,005,574
13,500 +45.5% 74.49 US$1,005,574
2026-03-16 2026-03-13 B Purchase

Chief Executive Officer

Executive Director
13,360 +17.1%
69.85
US$933,224
13,360 +17.1% 69.85 US$933,224
2026-03-16 2026-03-12 B Purchase Non-Executive Director
142,000 +6.2%
70.13
US$9,957,963
142,000 +6.2% 70.13 US$9,957,963
2026-03-16 2026-03-12 B Purchase Non-Executive Director
14,200 +91.9%
70.07
US$995,015
14,200 +91.9% 70.07 US$995,015
2026-03-16 2026-03-12 B Purchase

Chief Executive Officer

Executive Director
900 +1.2%
68.87
US$61,980
900 +1.2% 68.87 US$61,980
2026-03-16 2026-03-06 B Purchase Non-Executive Director
3 +37.5%
73.93
US$222
3 +37.5% 73.93 US$222
2026-03-16 2026-02-09 B Purchase Non-Executive Director
146 +55.5%
74.63
US$10,896
146 +55.5% 74.63 US$10,896
2026-03-16 2025-12-15 S Sale Non-Executive Director
3 -27.3%
63.35
US$190
3 -27.3% 63.35 US$190
2025-12-12 2025-12-12 B Purchase

EVP, General Counsel

Officer
3,100 +25.8%
63.48
US$196,788
3,100 +25.8% 63.48 US$196,788
2026-03-16 2025-12-10 S Sale Non-Executive Director
25 -69.4%
65.27
US$1,632
25 -69.4% 65.27 US$1,632
2026-03-16 2025-11-18 S Sale Non-Executive Director
187 -41.6%
65.42
US$12,234
187 -41.6% 65.42 US$12,234
2025-11-07 2025-11-07 PrS Proposed sale

Former Officer

Officer
4,060
62.51
US$253,810
4,060 62.51 US$253,810
2026-03-16 2025-10-30 B Purchase Non-Executive Director
39 +inf%
63.64
US$2,482
39 +inf% 63.64 US$2,482
2026-03-16 2025-09-29 S Sale Non-Executive Director
7 -100.0%
60.87
US$426
7 -100.0% 60.87 US$426
2026-03-16 2025-08-27 B Purchase Non-Executive Director
71 +18.7%
66.91
US$4,751
71 +18.7% 66.91 US$4,751
2025-08-08 2025-08-07 B Purchase Non-Executive Director
15,450 +inf%
64.80
US$1,001,183
15,450 +inf% 64.80 US$1,001,183
2025-08-07 2025-08-07 B Purchase

Chief Executive Officer

Executive Director
15,300 +24.6%
64.95
US$993,714
15,300 +24.6% 64.95 US$993,714
2025-05-23 2025-05-22 B Purchase Non-Executive Director
4,500 +140.8%
76.05
US$342,240
4,500 +140.8% 76.05 US$342,240
2025-05-20 2025-05-19 B Purchase Non-Executive Director
850 +55.1%
77.42
US$65,807
850 +55.1% 77.42 US$65,807
2025-05-19 2025-05-19 PrS Proposed sale

Officer

Officer
2,400
77.34
US$185,604
2,400 77.34 US$185,604
2025-05-19 2025-05-19 S Sale

CAO, SVP & Controller

Officer
2,400 -41.9%
77.34
US$185,604
2,400 -41.9% 77.34 US$185,604
2025-05-19 2025-05-19 B Purchase

EVP, General Counsel

Officer
2,000 +20.0%
77.58
US$155,156
2,000 +20.0% 77.58 US$155,156
2025-05-19 2025-05-19 B Purchase

EVP, General Counsel

Officer
10,000 +inf%
77.22
US$772,200
10,000 +inf% 77.22 US$772,200
2025-05-15 2025-05-15 B Purchase Non-Executive Director
300 +7.0%
75.32
US$22,596
300 +7.0% 75.32 US$22,596
2025-05-15 2025-05-15 B Purchase Non-Executive Director
3,700 +612.6%
75.33
US$278,718
3,700 +612.6% 75.33 US$278,718
2025-05-09 2025-05-09 B Purchase

Chief Executive Officer

Executive Director
24,300 +64.3%
73.97
US$1,797,456
24,300 +64.3% 73.97 US$1,797,456
2025-05-09 2025-05-08 B Purchase

Chief Executive Officer

Executive Director
700 +1.9%
74.00
US$51,797
700 +1.9% 74.00 US$51,797
2025-03-06 2025-03-05 B Purchase Non-Executive Director
6,500 +inf%
80.44
US$522,833
6,500 +inf% 80.44 US$522,833
2025-03-05 2025-03-04 B Purchase

CEO

Executive Director
25,000 +581.4%
80.24
US$2,005,878
25,000 +581.4% 80.24 US$2,005,878
2024-11-12 2024-11-11 PrS Proposed sale

Officer

Officer
5,000
91.76
US$458,775
5,000 91.76 US$458,775
2024-11-12 2024-11-11 S Sale

President, Nourish

Officer
5,000 -60.7%
91.76
US$458,775
5,000 -60.7% 91.76 US$458,775
2024-06-14 2024-06-13 S Sale

President, Pharma Solutions

Officer
2,588 -23.3%
95.66
US$247,560
2,588 -23.3% 95.66 US$247,560
2024-06-13 2024-06-13 PrS Proposed sale

Officer

Officer
2,588
95.66
US$247,561
2,588 95.66 US$247,561
2026-03-25 2023-10-25 S Sale Non-Executive Director
15 -3.1%
66.05
US$991
15 -3.1% 66.05 US$991
2026-03-25 2023-08-04 B Purchase Non-Executive Director
15 +3.2%
80.95
US$1,214
15 +3.2% 80.95 US$1,214
2026-03-25 2023-05-30 S Sale Non-Executive Director
15 -3.1%
77.49
US$1,162
15 -3.1% 77.49 US$1,162
2023-05-12 2023-05-11 S Sale

President, Scent

Officer
1,972 -17.8%
86.35
US$170,282
1,972 -17.8% 86.35 US$170,282
2023-05-11 2023-05-11 PrS Proposed sale

Officer

Officer
1,972
86.35
US$170,282
1,972 86.35 US$170,282
2026-03-25 2023-03-24 B Purchase Non-Executive Director
10 +inf%
84.27
US$843
10 +inf% 84.27 US$843
2022-08-15 2022-08-11 PlS Planned sale

EVP, Operations

Officer
10,000 -36.7%
125.00
US$1,250,000
10,000 -36.7% 125.00 US$1,250,000
2022-06-02 2022-06-01 PlS Planned sale

President, Scent

Officer
629 -7.1%
132.59
US$83,399
629 -7.1% 132.59 US$83,399
2022-05-03 2022-05-02 PlS Planned sale

President, Scent

Officer
630 -6.7%
121.68
US$76,658
630 -6.7% 121.68 US$76,658
2021-05-17 2021-05-14 B Purchase Non-Executive Director
1,000 +392.2%
140.39
US$140,386
1,000 +392.2% 140.39 US$140,386
2021-05-17 2021-05-13 S Sale

President Health & Biosciences

Officer
1,332 -46.8%
138.47
US$184,442
1,332 -46.8% 138.47 US$184,442
2020-04-17 2020-04-16 PlS Planned sale

Group President Fragrance

Officer
156 -0.5%
118.04
US$18,414
156 -0.5% 118.04 US$18,414
2020-04-01 2020-03-30 B Purchase Large shareholder
100 +0.0%
112.78
US$11,278
100 +0.0% 112.78 US$11,278
2020-04-01 2020-03-30 B Purchase Large shareholder
2,100 +0.0%
111.92
US$235,032
2,100 +0.0% 111.92 US$235,032
2020-04-01 2020-03-30 B Purchase Large shareholder
6,392 +0.0%
111.25
US$711,110
6,392 +0.0% 111.25 US$711,110
2020-04-01 2020-03-30 B Purchase Large shareholder
900 +0.0%
110.04
US$99,036
900 +0.0% 110.04 US$99,036
2020-03-31 2020-03-27 B Purchase Large shareholder
3,200 +0.0%
112.76
US$360,832
3,200 +0.0% 112.76 US$360,832
2020-03-31 2020-03-27 B Purchase Large shareholder
15,100 +0.1%
111.93
US$1,690,143
15,100 +0.1% 111.93 US$1,690,143
2020-03-31 2020-03-27 B Purchase Large shareholder
16,689 +0.1%
110.99
US$1,852,312
16,689 +0.1% 110.99 US$1,852,312
2020-03-31 2020-03-27 B Purchase Large shareholder
18,817 +0.1%
110.14
US$2,072,504
18,817 +0.1% 110.14 US$2,072,504
2020-03-30 2020-03-26 B Purchase Large shareholder
2,911 +0.0%
114.02
US$331,912
2,911 +0.0% 114.02 US$331,912
2020-03-30 2020-03-26 B Purchase Large shareholder
7,789 +0.0%
113.62
US$884,986
7,789 +0.0% 113.62 US$884,986
2020-03-30 2020-03-26 B Purchase Large shareholder
8,012 +0.0%
112.42
US$900,709
8,012 +0.0% 112.42 US$900,709
2020-03-30 2020-03-26 B Purchase Large shareholder
10,900 +0.0%
111.52
US$1,215,568
10,900 +0.0% 111.52 US$1,215,568
2020-03-30 2020-03-26 B Purchase Large shareholder
2,500 +0.0%
110.42
US$276,050
2,500 +0.0% 110.42 US$276,050
2020-03-30 2020-03-26 B Purchase Large shareholder
8,201 +0.0%
109.47
US$897,763
8,201 +0.0% 109.47 US$897,763
2020-03-30 2020-03-26 B Purchase Large shareholder
5,223 +0.0%
108.38
US$566,069
5,223 +0.0% 108.38 US$566,069
2020-03-30 2020-03-26 B Purchase Large shareholder
2,700 +0.0%
107.43
US$290,061
2,700 +0.0% 107.43 US$290,061
2020-03-30 2020-03-26 B Purchase Large shareholder
1,300 +0.0%
106.04
US$137,852
1,300 +0.0% 106.04 US$137,852
2020-03-30 2020-03-26 B Purchase Large shareholder
500 +0.0%
104.87
US$52,435
500 +0.0% 104.87 US$52,435
2020-03-27 2020-03-25 B Purchase Large shareholder
100 +0.0%
108.45
US$10,845
100 +0.0% 108.45 US$10,845
2020-03-27 2020-03-25 B Purchase Large shareholder
1,700 +0.0%
107.73
US$183,141
1,700 +0.0% 107.73 US$183,141
2020-03-27 2020-03-25 B Purchase Large shareholder
10,500 +0.0%
106.64
US$1,119,720
10,500 +0.0% 106.64 US$1,119,720
2020-03-27 2020-03-25 B Purchase Large shareholder
37,220 +0.2%
105.80
US$3,937,876
37,220 +0.2% 105.80 US$3,937,876
2020-03-27 2020-03-25 B Purchase Large shareholder
23,150 +0.1%
104.87
US$2,427,740
23,150 +0.1% 104.87 US$2,427,740
2020-03-27 2020-03-25 B Purchase Large shareholder
2,705 +0.0%
103.92
US$281,104
2,705 +0.0% 103.92 US$281,104
2020-03-27 2020-03-25 B Purchase Large shareholder
5,471 +0.0%
102.71
US$561,926
5,471 +0.0% 102.71 US$561,926